Related Experiment Videos
Primitive hematopoietic stem cells shows a polyclonal pattern in myelodysplastic syndromes
Francesca Guidetti1, Sandra Grazioli, Francesca Capelli
1Department of Medical Science, University of Piemonte Orientale Amedeo Avogadro Novara, Italy.
Haematologica
|February 3, 2004
Summary
Myelodysplastic syndromes (MDS) show clonal hematopoiesis. In MDS, immature stem cells remain polyclonal, suggesting a biological advantage of neoplastic clones over normal stem cells.
Area of Science:
- Hematology
- Stem Cell Biology
- Genetics
Background:
- Clonal hematopoiesis is characteristic of myelodysplastic syndromes (MDS).
- The specific roles of pluripotent stem cells and progenitor cells in MDS pathogenesis are not fully understood.
Purpose of the Study:
- To investigate the clonal origin of hematopoiesis in patients with myelodysplastic syndromes.
- To determine the contribution of pluripotent stem cells and progenitor cells to clonal hematopoiesis in MDS.
Main Methods:
- Analysis of X-chromosome inactivation patterns in peripheral blood cells (granulocytes, T-lymphocytes) and bone marrow progenitors/pluripotent stem cells from eight female MDS patients.
- Utilized the human androgen receptor locus polymorphism assay.
Main Results:
- Granulocytes and progenitor cells exhibited monoclonal origin in 7 out of 8 MDS cases.
- Immature stem cells displayed a non-clonal X-inactivation pattern and were detectable alongside clonal hematopoiesis at diagnosis.
- T-lymphocyte clonality showed heterogeneous patterns.
Conclusions:
- Hematopoiesis in MDS may be driven by a dominant neoplastic clone possessing a biological advantage.
- A residual polyclonal population of immature stem cells, likely normal, persists and retains in vitro growth capacity.
- These findings highlight the complex cellular dynamics in MDS, with neoplastic clones outcompeting normal stem cells.